Pharmaceutical giant GSK’s chief commercial officer, Luke Miels, will become CEO in January 2026, ...
Share trading in TruSpine Technologies Plc has been suspended after the company delayed the completi...
EMV Capital’s subsidiary Moirai Acquisitions has bought key assets from Destiny Pharma, the AIM-li...
When chief executive Steve Sanghera and chief commercial officer Jim Michel launched Inventus from a...
The CEO and finance director have been ousted from the board of listed MedTech ANGLE plc. The Sur...
Aston University and the University of Leeds have secured £3.4m to lead a national network assessin...
A Stevenage-based neuroscience company has raised an oversubscribed £50m Series B funding round to ...
AI-driven genomic analysis firm SeqOne has agreed a deal to acquire Congenica, a Cambridge-based com...
A MedTech targeting early detection of esophageal cancer has raised £32.5m in Series B funding. ...
Listed infection prevention products manufacturer Tristel has appointed CMR Surgical executive Anna ...
The details of the collapse of AMLo Biosciences into administration last month have been revealed. ...
Oxford-based OrganOx has been sold in a mammoth £1.1bn deal. The company’s pioneering liver pe...